What is the appropriate famotidine (Pepcid) dose for a child experiencing an allergic reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Famotidine Dosing for Allergic Reactions

For children experiencing anaphylaxis or severe allergic reactions, famotidine (Pepcid) should be dosed at 1 mg/kg IV (maximum 12.5-50 mg), diluted in 5% dextrose to 20 mL and administered over 5 minutes, but only as second-line adjunctive therapy after epinephrine has been given first.

Critical Context: Epinephrine is First-Line

Before discussing famotidine dosing, it's essential to emphasize that H2-antihistamines like famotidine should never be used alone in anaphylaxis 1. Epinephrine is the only first-line treatment for anaphylaxis and must be administered immediately (0.01 mg/kg IM of 1:1000 solution, maximum 0.3-0.5 mg) 1. Famotidine has a much slower onset of action than epinephrine and serves only as adjunctive therapy 1.

Famotidine Dosing Algorithm for Pediatric Allergic Reactions

For Anaphylaxis (After Epinephrine):

Dose: 1 mg/kg IV (alternatively reported as 12.5-50 mg range in children) 1

Preparation and Administration:

  • Dilute in 5% dextrose (D5W) to a total volume of 20 mL
  • Inject intravenously over 5 minutes 1
  • Can be given every 12 hours if needed 2

For Non-Anaphylactic Allergic Reactions:

Standard IV Dose: 0.25 mg/kg IV every 12 hours (maximum 40 mg/day) 2

  • Administer over at least 2 minutes or as a 15-minute infusion 2
  • This is the FDA-approved starting dose for pediatric patients 1-16 years of age

Alternative Higher Dose: Up to 0.5 mg/kg IV every 12 hours has been studied and may be used for more severe symptoms 2, 3

Age-Specific Considerations

Infants Under 1 Year:

  • Infants <3 months: Reduced clearance requires dose adjustment—consider 0.25 mg/kg IV once daily rather than every 12 hours 3
  • Infants 3-12 months: Standard dosing of 0.25 mg/kg IV every 12 hours is appropriate 3
  • No data available for infants <1 month of age 2

Children 1-16 Years:

  • Pharmacokinetics similar to adults 2, 4
  • Standard dosing applies: 0.25-0.5 mg/kg IV every 12 hours

Combination Therapy Rationale

The combination of an H1-antihistamine (diphenhydramine 1-2 mg/kg) plus an H2-antihistamine (famotidine) is superior to H1-antihistamine alone in managing anaphylaxis 1. This dual blockade addresses histamine-mediated symptoms more comprehensively, though both remain second-line to epinephrine.

Common Pitfalls to Avoid

  1. Never delay epinephrine to give famotidine first—this is the most critical error. Epinephrine must be administered immediately in anaphylaxis 1.

  2. Don't confuse famotidine with cimetidine—while cimetidine can be used at 4 mg/kg IV in adults, no pediatric dosage for cimetidine in anaphylaxis has been established 1.

  3. Avoid rapid IV push—famotidine should be given over at least 2 minutes (preferably 5 minutes when diluted) to minimize adverse effects 2.

  4. Don't use famotidine as monotherapy—it must be part of a comprehensive approach including epinephrine, fluids, oxygen, and monitoring 1, 5.

  5. Adjust for renal impairment—in children with moderate to severe renal insufficiency, reduce the dose to half or extend the dosing interval to 36-48 hours 2.

Practical Administration Notes

  • Onset of action: 1-3 hours (much slower than epinephrine's immediate effect) 1
  • Duration: Approximately 10-12 hours
  • Monitoring: Observe for 4-6 hours minimum after anaphylaxis, longer if severe 5
  • Continuation therapy: May continue H2-antihistamine (ranitidine or famotidine) twice daily for 2-3 days post-discharge to prevent biphasic reactions 5

Safety Profile

Famotidine is generally well-tolerated in children. Potential adverse effects include:

  • Agitation or irritability (most common in infants) 6
  • Headache 6
  • Somnolence 6
  • Transient elevation of liver enzymes (not typically drug-related) 7

No serious adverse events have been reported in pediatric studies 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.